Lannett and HEC will, in exchange for its financial contribution, receive a sub-license to a licensing arrangement between Ypsomed and Sanofi-Aventis Deutschland GmbH.
Comparable store sales excluding gas increased 7.9% in Q3, with an acceleration in growth rates in both the United States and Europe to 8.2% and 7.4%, respectively.
This order, which restrains the company from paying the Special Dividend, remains in effect until Nov. 10, 2022, unless within that time, an order is entered extending or dismissing the temporary restraining order.
The investment from 5th Century Partners will be used by the brand to help fund its ambitions, domestic and global expansions and new product innovations.